Abstract
To review the literature and attempt to define patient compliance with hormonal replacement therapy and physician prescription of these therapies.Review of selected literature.Population studies and clinical trials.Postmenopausal and postcastration women.Hormone replacement regimens.Descriptions and compliance by patients.In addition to the effective control of vasomotor hot flushes and atrophic genital changes in postmenopausal women, it is now well established that the long-term use of estrogen replacement therapy (ERT) or hormone replacement therapy (HRT) with estrogen and/or progestin offers prophylaxis against osteoporosis and cardiovascular arteriosclerotic disease, notably myocardial infarction. However, despite such documentation of benefit, it is estimated that < 20% of postmenopausal women in the United States have ever had ERT or HRT prescribed, < 40% of those for whom such treatment has been prescribed will continue it after 1 year, and that overall, > 70% of those for whom it has been prescribed are not compliant. It appears that this lack of prescription and compliance are the function of both physician and patient considerations. This paper presents reasons for such actions and reviews ways in which use can be improved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Gynecology & Obstetrics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
